Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid
Macromolecular Rapid Communications · 2023
DOI: 10.1002/marc.202300101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Rapid Communications, 2023. Verfasst von Deepak Kumar Sahel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS Pilani), Pilani Campus, Vidya Vihar, Pilani, Rajasthan, 333031, India. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Department of Biotechnology, India, Indian Council of Medical Research, Senior Research Fellowship.
Abstract (Originalsprache)
CRISPR/Cas9 has proven its accuracy and precision for gene editing by making a double‐strand break at the predetermined site. Despite being a mainstream gene editing tool, CRISPR/Cas9 has limitations for its in vivo delivery due to the physico‐chemical properties such as high molecular weight, supranegative charge, degradation in the presence of nucleases, etc. Hereby, a cationic lipopolymer is explored for its efficiency in delivering CRISPR/Cas9 plasmid (pCas9) in vitro and in vivo. The lipopolymer is utilized to form blank cationic nanoplexes having a zeta potential of +15.8 ± 0.7 mV. Being cationic, the blank nanoplexes are able to condense the pCas9 plasmid at a ratio of 1:20 with a complexation efficiency of ≈98% and show a size and zeta potential of ≈141 ± 16 nm and 4.2 mV ± 0.7, respectively. The pCas9‐loaded nanoplexes show a transfection efficiency of ≈69% in ARPE‐19 cells and show ≈22% of indel frequency, indicating the successful translation of Cas9 protein and guide RNA in the cytosol. Further, they are found to be stable under in vivo environment when given intravenously in Swiss albino mice. These lipopolymeric nanoplexes can be a potential carrier for CRISPR plasmids for genome editing applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS Pilani), Pilani Campus, Vidya Vihar, Pilani, Rajasthan, 333031, India.
- CSIR-Institute of Genomics and Integrated Biology, New Delhi, 110025, India.
- Centre for Comparative Medicine, Institute of Liver and Biliary Sciences (ILBS), New Delhi, 110070, India.
ORCID-Profile: Deepak Chitkara
Förderung
- Department of Biotechnology, India
- Indian Council of Medical Research
- Senior Research Fellowship
Zitieren
APA
Sahel, D. K., Goswami, S. G., Jatyan, R., Kumari, A., Mittal, A., Ramalingam, S., & Chitkara, D. (2023). Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.202300101
Vancouver
Sahel DK, Goswami SG, Jatyan R, Kumari A, Mittal A, Ramalingam S, et al. Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid. Macromolecular Rapid Communications. 2023. doi:10.1002/marc.202300101
BibTeX
@article{Sahel2023,
author = {Sahel, Deepak Kumar and Goswami, Sangam Giri and Jatyan, Reena and Kumari, Anupma and Mittal, Anupama and Ramalingam, Sivaprakash and Chitkara, Deepak},
title = {Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid},
journal = {Macromolecular Rapid Communications},
year = {2023},
doi = {10.1002/marc.202300101}
}
EUVIMED